MedTrace Logo

Validation of an Italian Questionnaire of Adherence to the Ketogenic Diet

NCT05377762 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2022-06-22

No results posted yet for this study

Summary

The ketogenic diet (KD) represents an effective and safe non-drug treatment for drug-resistant epilepsy in pediatric and adult age based on normocaloric, hyperlipidic (80-90% of the daily energy), normoproteic and hypoglucidic dietary regimen. Adherence to treatment with KD is often difficult in the long term, for the patient and for caregivers, especially in adolescence. There are no tools in the literature other than monitoring ketonemia to measure adherence to the diet. A quality tool, validated by experts, on a large population, would allow for a more solid assessment of adherence to treatment, facilitating clinicians in the interpretation of efficacy results and in implementing an early intervention to adjust the therapy.

Conditions

Sponsors & Collaborators

  • University of Sao Paulo

    collaborator OTHER

  • University of Pavia

    lead OTHER

Principal Investigators

  • Valentina De Giorgis · University of Pavia

Eligibility

Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-16
Primary Completion
2022-07-31
Completion
2022-09-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05377762 on ClinicalTrials.gov